FibroBiologics completes manufacturing of drug for diabetic foot ulcer trial
Go back to FibroBiologics completes manufacturing of drug for diabetic foot ulcer trial| (NASDAQ: FBLG) | Delayed: 0.82 +0.01 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.81 | 52 Week High | $ | |||
| Open | $0.82 | 52 Week Low | $ | |||
| Day High | $0.84 | P/E | N/A | |||
| Day Low | $0.77 | EPS | $ | |||
| Volume | 134,915 | |||||
